首页 › 基金 › DeepCurrents Investment Group LLC › BBIO
DeepCurrents Investment Group LLC 对 BBIO 的持仓历史
BRIDGEBIO PHARMA INC · 医疗保健
DeepCurrents Investment Group LLC 在 Q3 2026 的 13F 申报中披露持有 BBIO(BRIDGEBIO PHARMA INC)57,745,000 股,市值约 US$89.8M,约占其申报组合的 2.97%,在其申报持仓中市值排名第 6 位。 DeepCurrents Investment Group LLC 最近 13 个申报季度中有 6 个季度披露了 BBIO 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
DeepCurrents Investment Group LLC 对 BBIO 的持仓演变
DeepCurrents Investment Group LLC 于 Q3 2023 首次披露 BBIO 持仓:17,855,000 股(约 US$13.5M)。 该持仓在 Q3 2026 达到峰值 57,745,000 股,市值约 US$89.8M。 在 6 次申报中,DeepCurrents Investment Group LLC 2 次增持、1 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 57,745,000 股、市值约 US$89.8M,环比增持 7,500,000 股。。 持仓曾出现大幅变动:Q1 2024 减持约 90% (随后一个季度股价下跌 18%)、Q2 2026 增持约 429% (随后一个季度股价下跌 12%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 17.86M | $13.51M | 新进 |
| Q4 2023 | 17.86M | $15.13M | 持有 |
| Q1 2024 | 1.78M | $1.69M | 减持 |
| Q1 2026 | 9.50M | $17.14M | 新进 |
| Q2 2026 | 50.24M | $89.75M | 增持 |
| Q3 2026 | 57.74M | $89.83M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BBIO 与 13F 数据
BBIO(BRIDGEBIO PHARMA INC)属于医疗保健行业。我们追踪的基金中还有 38 只申报持有 BBIO,申报仓位最大的包括:Jupiter Topco LLC (US$1.05B), 骏利亨德森集团 (US$978.6M), 法拉龙资本管理 (US$800.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BBIO 的基金
- Jupiter Topco LLC 14.11M 股 · $1.05B · Q2 2026
- 骏利亨德森集团 13.18M 股 · $978.61M · Q1 2026
- 法拉龙资本管理 10.74M 股 · $800.14M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 10.74M 股 · $800.14M · Q2 2026
- 维京环球投资 9.95M 股 · $741.02M · Q2 2026
- VIKING GLOBAL INVESTORS LP 9.95M 股 · $741.02M · Q2 2026
- Aisling Capital Management LP 3.09M 股 · $203.30M · Q3 2026
- CAPSTONE INVESTMENT ADVISORS, LLC 69.87M 股 · $124.49M · Q2 2026
- SC US (TTGP), LTD. 1.86M 股 · $122.41M · Q3 2026
- Frazier Life Sciences Management, L.P. 1.55M 股 · $115.31M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 1.37M 股 · $102.27M · Q2 2026
- Hood River Capital Management LLC 1.35M 股 · $100.36M · Q2 2026
更多关于 DeepCurrents Investment Group LLC
常见问题
How long has DeepCurrents Investment Group LLC held BBIO?
DeepCurrents Investment Group LLC has disclosed BBIO holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
What is DeepCurrents Investment Group LLC's current position in BBIO?
As of Q3 2026, DeepCurrents Investment Group LLC holds 57.74M shares of BBIO (BRIDGEBIO PHARMA INC), valued at $89.83M, representing 2.97% of its reported portfolio and ranking #6.
Has DeepCurrents Investment Group LLC been buying or selling BBIO?
In the latest 13F filing (Q3 2026), DeepCurrents Investment Group LLC increased its position in BBIO. The position peaked in Q3 2026 at 57.74M shares.
Which other funds hold BBIO?
Other major institutional holders of BBIO include Jupiter Topco LLC, 骏利亨德森集团, 法拉龙资本管理, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.